These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2902863)

  • 61. [Current risk of HIV infection by blood transfusions].
    Braun RW
    Hautarzt; 1989 Jul; 40(7):461. PubMed ID: 2759863
    [No Abstract]   [Full Text] [Related]  

  • 62. [Seroepidemiology of HIV-1 and HIV-2 in the USSL 76 area--Casale M.To. Preliminary study].
    Deambrogio V; Guaschino R; Mongiò F; Schettino G; Gatti G; Fruttaldo L
    Minerva Med; 1991 Sep; 82(9):573-5. PubMed ID: 1945007
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [New methods of interlaboratory monitoring of HIV-1 ELISA kits. Comparative study of 2 periods: 1/12/1988 to 15/4/1989 and 15/4/1989 to 31/8/1989. Le Groupe Rétrovirus de la Sociètè Nationale de Transfusion Sanguine].
    North ML; Noël L; Couroucé AM
    Rev Fr Transfus Hemobiol; 1990 Jun; 33(3):211-22. PubMed ID: 2206168
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Screening of African sera stored for more than 17 years for HIV antibodies by site-directed serology.
    Chiodi F; Biberfeld G; Parks E; Norrby E; Mufson M
    Eur J Epidemiol; 1989 Mar; 5(1):42-6. PubMed ID: 2707394
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Spread pattern of HIV-2 in patients at risk. Evaluation of serologic markers].
    Ollero M; Pujol E; Márquez P; Gimeno A; Alcoucer R; Mora D
    An Med Interna; 1991 Mar; 8(3):116-21. PubMed ID: 1893016
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Human immunodeficiency virus type 2 in Spain.
    Soriano V; Tor J; Ribera A
    Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):568. PubMed ID: 2569973
    [No Abstract]   [Full Text] [Related]  

  • 67. Specific synthetic peptides for detection of and discrimination between HIV-1 and HIV-2 infection.
    Broliden PA; Rudén U; Ouattara AS; de Thé G; Sølver E; Trojnar J; Wahren B
    J Acquir Immune Defic Syndr (1988); 1991; 4(10):952-8. PubMed ID: 1679844
    [TBL] [Abstract][Full Text] [Related]  

  • 68. HIV-2 prevalence in three rural regions of Sénégal: low levels and heterogeneous distribution.
    Le Guenno B; Pison G; Enel C; Lagarde E; Seck C
    Trans R Soc Trop Med Hyg; 1992; 86(3):301-2. PubMed ID: 1357787
    [No Abstract]   [Full Text] [Related]  

  • 69. Detection of HIV antibodies in seronegative subjects at risk of HIV infection.
    Bedarida G; Panzeri MP; Lizioli A; D'Agostino F; Cambié G; Nardella ML; Berto E; Crocchiolo P
    AIDS; 1989 Sep; 3(9):613-4. PubMed ID: 2506907
    [No Abstract]   [Full Text] [Related]  

  • 70. Evaluation of performance of reused HIVCHEK 1 + 2 test blocks which have shown negative result: a reliable method for rural hospital?
    Acaye GL; Ansaloni L; Tocalli E
    Trop Doct; 1995 Apr; 25(2):54-5. PubMed ID: 7778194
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clinical significance of HIV-2 infection in West Africa.
    Kanki PJ
    AIDS Clin Rev; 1989; ():95-108. PubMed ID: 2577365
    [No Abstract]   [Full Text] [Related]  

  • 72. [HIV infections among Turkish citizens who have lived in foreign countries].
    Demiröz P; Irmak H; Sengül A; Ceviz HA; Kocabalkan F
    Mikrobiyol Bul; 1989 Jul; 23(3):203-9. PubMed ID: 2487460
    [TBL] [Abstract][Full Text] [Related]  

  • 73. HIV 2 infection among blood donors and other subjects in France. The "Retrovirus" Study Group of the French Society of Blood Transfusion.
    Courouce AM; Barin F; Baudelot J; Chamaret S; Gueguen M; Janot C; Lemaire JM; Maniez M; Mesnier F; Mouillot L
    Transfusion; 1989 May; 29(4):368-70. PubMed ID: 2718237
    [TBL] [Abstract][Full Text] [Related]  

  • 74. HIV-2 in Spain.
    Soriano V; Tor J; Ribera A
    Transfusion; 1989 Oct; 29(8):749. PubMed ID: 2572079
    [No Abstract]   [Full Text] [Related]  

  • 75. Vertical transmission of HIV-2.
    Matheron S; Courpotin C; Simon F; Di Maria H; Balloul H; Bartzack S; Dormont D; Brun Vezinet F; Saimot AG; Coulaud JP
    Lancet; 1990 May; 335(8697):1103-4. PubMed ID: 1970407
    [No Abstract]   [Full Text] [Related]  

  • 76. Are tuberculosis wards a risk factor for HIV in Africa?
    Fox E; Constantine NT; Aurégan G; el-Ghorab NM; Chakib-Saad ; Abbatte EA
    Trop Geogr Med; 1990 Jul; 42(3):286-8. PubMed ID: 2293440
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Custom-designed synthetic peptide immunoassays for distinguishing HIV type 1 and type 2 infections.
    Gnann JW; Smith LL; Oldstone MB
    Methods Enzymol; 1989; 178():693-714. PubMed ID: 2481220
    [No Abstract]   [Full Text] [Related]  

  • 78. The false-positive and false-negative predictive value of HIV antibody test in the Chinese population.
    Liu P; Shi Z; Wang C; Yang H; Li L; Dai Y; Liu Y; Sun J; Pu Y
    J Med Screen; 2008; 15(2):72-5. PubMed ID: 18573774
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Drug abusers - a new high risk population for HIV infection in Orissa.
    Pal BB; Khuntia HK; Acharya AS; Chhotray GP
    Indian J Med Microbiol; 2003; 21(4):262-4. PubMed ID: 17643039
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Antibodies to gag gene coded polypeptides of type D retroviruses in healthy people from Guinea-Bissau.
    Morozov VA; Saal F; Gessain A; Terrinha A; Périès J
    Intervirology; 1991; 32(4):253-7. PubMed ID: 1650766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.